Leading Oncologist – Urologic Cancer
Position: Head of the Urological Tumors Unit
Hospital: Oncology Department, Sourasky Medical Center, Ichilov Hospital, Tel Aviv
Dr. Daniel Keizman was included in Forbes magazine’s list of the best doctors in Israel
Qualified Medical Consultation Online, Second Opinion
Private Medical Consultation and Second Opinion
- Early and Metastatic stages of: Urinary tract tumors
- Kidney cancer
- Testicular cancer
- Prostate cancer
- Bladder Cancer
- New Diagnostics Protocols for Urologic Cancer
- Oncotests
- Oncotests for Prostate Cancer Personalized Treatment
- Advanced urologic cancer treatment
- Chemotherapy
- Radiation therapy
- Hormone therapy
- Brachytherapy
Send Your Medical Files Book Consultation Now
Professional Experience Dr. Daniel Keizman
- Head of the Urological Tumors Unit (prostate, kidney, bladder) at the Oncology Department, Tel Aviv Sourasky Medical Center.
- Head of the Urological Tumors Service at Meir Hospital.
Education
- 2001-2005: Residency in Internal Medicine at Tel Aviv Medical Center
- 2005-2008: Residency in Oncology at Tel Aviv Medical Center
- 2008-2011: Fellowship at the Johns Hopkins Cancer Center in Baltimore, USA
- 2011-2017: Head of the Urological Tumor Service at Meir Hospital
- 2017-2019: Head of the Urological Tumor Unit at Meir Hospital
Professional Associations
- Israeli Society of Clinical Oncology and Radiotherapy.
Scientific Research and Treatment Discoveries
Dr. Keizman is actively engaged in academic activity and is the author and coauthor of more than 50 publications in scientific journals.
Among his last publications are studies such as :
- Rucaparib or Physician’s Choice in Metastatic Prostate Cancer
- Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma
- Erdafitinib treatment in metastatic urothelial carcinoma: a real-world analysis
- and many others.
More publications of Dr. Keizman: https://pubmed.ncbi.nlm.nih.gov/?term=KEIZMAN%20DANIEL
